Complement in patients receiving maintenance hemodialysis: Functional screening and quantitative analysis

BMC Nephrology

Volumn 11, Issue 1, 2010, Pages

  Inoshita, Hiroyuki ^a   Ohsawa, Isao ^a   Kusaba, Gaku ^a   Ishii, Masaya ^a   Onda, Kisara ^a   Horikoshi, Satoshi ^a   Ohi, Hiroyuki ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR D; LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; MANNOSE BINDING LECTIN; PROPERDIN; UNCLASSIFIED DRUG; COMPLEMENT;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT BLOOD LEVEL; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEFICIENCY; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS PATIENT; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MORTALITY; NEPHELOMETRY; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; TURBIDIMETRY; COMPARATIVE STUDY; EVALUATION; GENETICS; IMMUNOLOGY; MASS SCREENING; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY;

COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; MASS SCREENING; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 78649716915     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-11-34     Document Type: Article

References (25)

1. Complement. First of two parts. MJ Walport, N Engl J Med 2001 344 1058 1066 10.1056/NEJM200104053441406 11287977
2. Complement. Second of two parts. MJ Walport, N Engl J Med 2001 344 1140 1144 10.1056/NEJM200104123441506 11297706
3. Inherited complement deficiencies and bacterial infections. F Tedesco, Vaccine 2008 30 Suppl 8 13 18
4. Complement in human diseases: Lessons from complement deficiencies. M Botto M Kirschfink P Macor MC Pickering R Würzner F Tedesco, Mol Immunol 2009 46 2774 2783 10.1016/j.molimm.2009.04.029 19481265
5. Function and regulation of the complement system in cardiovascular diseases. R Oksjoki PT Kovanen S Meri MO Pentikainen, Front Biosci 2007 12 4696 4708 10.2741/2419 17485406
6. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells. LA Trouw HM Nielsen L Minthon E Londos G Landberg R Veerhuis S Janciauskiene AM Blom, Mol Immunol 2008 45 3649 3660 10.1016/j.molimm.2008.04. 025 18556068
7. the molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. JD Reveille, Curr Opin Rheumatol 1991 3 722 730 10.1097/00002281- 199110000-00002 1751307
8. Mannan-binding lectin (MBL) in women with tumors of the reproductive system. AS Swierzko K Florczak M Cedzyski J Szemraj D Wydra L Bak-Romaniszyn J Emerich Z Suowska, Cancer Immunol Immunother 2007 56 959 971 10.1007/s00262-006-0250-7 17131120
9. Epidemiological perspective on infections in chronic dialysis patients. WE Bloembergen FK Port, Adv Ren Peplace Ther 1996 3 201 207
10. New molecular aspects of chronic uraemia and dialysisrelated immunocompetent cell activation. B Descamps-Latscha P Jungers, Nephrol Dial Transplant 1996 11 suppl 2 121 124 8804011
11. Complement analysis in the 21st century. TE Mollnes TS Jokiranta L Truedsson B Nilsson S Rodriguez de Cordoba M Kirschfink, Mol Immunol 2007 44 3838 3849 10.1016/j.molimm.2007.06.150 17768101
12. Mannan binding lectin concentration and risk of miscarriage. DC Kilpatrick L Starrs S Moore V Souter WA Liston, Hum Reprod 1999 14 2379 2380 10.1093/humrep/14.9.2379 10469715
13. Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. M Møller-Kristensen JC Jensenius L Jensen N Thielens V Rossi G Arlaud S Thiel, J Immunol Methods 2003 282 159 167 14604549
14. A family with complement factor D deficiency. DH Biesma AJ Hannema H van Velzen-Blad L Mulder R van Zwieten I Kluijt D Roos, J Clin Invest 2001 108 233 240 11457876
15. A second variant of properdin deficiency: the detection of properdin at low concentrations in affected males. AG Sjöholm C Söderström LA Nilsson, Complement 1988 5 130 140 3141111
16. The role of the complement system in renal injury. LA Hebert FG Cosio DJ Birmingham, Semin Nephrol 1992 12 408 427 1410866
17. Acquired Loss of Erythrocyte Complement Receptor Type 1 in Patients with Diabetic Nephropathy Undergoing Hemodialysis. M Wakabayashi H Ohi M Tamano K Onda T Fujita Y Tomino, Nephron Exp Nephrol 2006 12 89 e95 10.1159/000094547 (Pubitemid 44580363)
18. Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient. H Inoshita T Gohda H Io K Kaneko C Hamada S Horikoshi Y Tomino, Clin Nephrol 2008 69 58 62 18218318
19. Metabolic impact on serum levels of complement component 3 in Japanese patients. I Ohsawa H Inoshita M Ishii G Kusaba N Sato S Mano K Onda T Gohda S Horikoshi H Ohi Y Tomino, J Clin Lab Anal 2010 24 113 118 10.1002/jcla.20372 20333766
20. Shotgun proteomics implicates protease inhibition and complement activation in the anti-inflammatory properties of HDL. T Vaisar S Pennathur PS Green SA Gharib AN Hoofnagle MC Cheung J Byun S Vuletic S Kassim P Singh H Chea RH Knopp J Brunzell R Geary A Chait XQ Zhao K Elkon S Marcovina P Ridker JF Oram JW Heinecke, J Clin Invest 2007 117 746 756 10.1172/JCI26206 17332893
21. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. G Engström B Hedblad L Janzon F Lindgarde, Eur J Cardiovasc Prev Rehabil 2007 14 392 397 17568238
22. The role of complement in biomaterial-induced inflammation. B Nilsson KN Ekdahl TE Mollnes JD Lambris, Mol Immunol 2007 44 82 94 10.1016/j.molimm.2006. 06.020 16905192
23. Effects of complement activation by hemodialysis membranes. AK Cheung LW Henderson, Am J Nephrol 1986 6 81 91 10.1159/000167060 3518458
24. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). LA Hebert DJ Birmingham JJ Dillon FG Cosio XP Shen, J Am Soc Nephrol 1994 4 1786 1791 8068876
25. Low CR1 (C3b receptor) level on erythrocytes is associated with poor prognosis in hemodialysis patients. H Ohi M Tamano N Okada, Nephron Clin Pract 2008 108 23 c27 10.1159/000112478 18075277